medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2004; 32 (4)

Superior Vena Cava Syndrome

Fernández JB, Peña PC, Almagro M, Rodríguez LJ, Fonseca E, Cageao X
Full text How to cite this article

Language: Spanish
References: 15
Page: 163-166
PDF size: 345.95 Kb.


Key words:

superior vena cava syndrome, cutaneous signs, lung carcinoma.

ABSTRACT

Cutaneous signs of superior vena cava syndrome (SVCS) are numerous including dilated and tortuous veins vertically orientated on thorax wall, upper extremity and trunk swelling with cyanotic or reddish skin, dilated venous branches of neck and conjunctival sufussion. When these features are present, we must exclude malignancy or metastasic intrathoracic carcinoma. We report two patients whose cutaneous lesions were the first sign of an underlying malignancy which caused a superior vena cava syndrome.


REFERENCES

  1. Jackson Allison E, Arshad JA, Mccaskill RL, Brown CK. A breathless, bloated young man. Superior Vena Cava Syndrome. NCMJ 2001; 62: 220-3.

  2. Wudel LJ, Nesbitt JC. Superior vena cava syndrome. Curr Treat Opt Oncol 2001; 2: 77-9.

  3. 3 Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: A modern management strategy. Clin Oncol 1997; 9: 83-9.

  4. Markman M. Diagnosis and management of superior vena cava syndrome. Clev Clin Jour Med 1999; 66: 59-61.

  5. Stewart IE. Superior vena cava syndrome: An oncologic complication. Sem Oncol Nurs 1996; 12: 312-7.

  6. I. Haapoja S, Blendowski C. Superior vena cava syndrome. Sem Oncol Nurs 1999; 15: 183-9.

  7. Bauset R. Pacemaker-induced superior vena cava síndrome: A case report and review of management strategy. Can J Cardiol 2002; 18: 1229-31.

  8. Porte H, Metois D, Finzi L. Superior vena cava syndrome of malignant origin. Which surgical procedure for which diagnosis? Eur Jour Car-Thor Sur 2000; 17: 384-8.

  9. Laguna P, Gazapo T, Murillas J, Martín H, et al. Síndrome de vena cava superior: análisis de 81 casos. An Med Interna 1998; 15: 470-5.

  10. Christodoulou CS, Díaz JD. Recurrent facial angioedema with elevated antinuclear antibodies. Ann Allergy 1997; 79: 397-01.

  11. Gutiérrez C, Vidal E. Edema cérvicofacial, ingurgitación yugular y circulación colateral en el tórax. Piel 2003; 4: 71-3.

  12. Schraufnagel DE, Hill R, Leech JA. Superior vena cava obstruction. Am J Med 1981; 70: 1169.

  13. Van Dellen RG, Maddox DE, Dutta EJ. Masqueraders of angioedema and urticaria. Ann Allergy 2002; 88: 10-5.

  14. Tanigawa N, Sawada S, Mishima K. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Act Radiol 1998; 39: 669-74.

  15. Sha R, Sabanathan S, Lowe RA, Mearns AJ. Stenting in malignant obstruction of superior vena cava. J Thorac Cardiovasc Surg 1996; 112: 335-40.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2004;32